A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer.

Authors

Shore ND, Guerrero S, Sanahuja RM, Gambús G, Parente A.

Journal

Clin Ther

Year

2019

Volume

Mar;41

Issue

(3)

Pages

412-425

21st Century Oncology Physicians

Back
To top